SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015861
Filing Date
2021-08-05
Accepted
2021-08-05 16:15:38
Documents
42
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nltx-20210630.htm   iXBRL 10-Q 1063686
2 EX-31.1 exhibit3112021q2.htm EX-31.1 9503
3 EX-31.2 exhibit3122021q2.htm EX-31.2 9566
4 EX-32.1 exhibit3212021q2.htm EX-32.1 6867
  Complete submission text file 0001628280-21-015861.txt   3656280

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nltx-20210630.xsd EX-101.SCH 19754
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nltx-20210630_cal.xml EX-101.CAL 30430
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nltx-20210630_def.xml EX-101.DEF 92873
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nltx-20210630_lab.xml EX-101.LAB 336227
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nltx-20210630_pre.xml EX-101.PRE 205819
10 EXTRACTED XBRL INSTANCE DOCUMENT nltx-20210630_htm.xml XML 442712
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 211148380
SIC: 2834 Pharmaceutical Preparations